Stock Updates

How has Becton, Dickinson and Company:(NYSE:BDX) performed recently?

Becton, Dickinson and Company (NYSE: BDX) is a large market cap stock with a market cap of 37389.67. It is in the Medical Instruments & Supplies industry and sector Healthcare, with a current P/E of 33.44, a forward P/E of 18.54 and EPS of 5.25. At a stock price of 175.47 (0.76%) it has a dividend yield of 1.50%.

EPS growth for the last five years have been -6.30%, more recently this last year it has grown by -44.10%. The next year growth is going to be about 10.47% and more long-term 13.37% after five years. EPS growth quarter over quarter is 208.50%. Sales growth for the past five years have been 7.60% and sales growth quarter over quarter is -48.80%.

For performance, Becton, Dickinson and Company the past week has seen a gain of 0.93%. For the last month performance for Becton, Dickinson and Company is -0.28%. While the last quarter is 5.49% and half year, 20.00%. Finally for the year, performance is 24.86%.

The 52-week high for Becton, Dickinson and Company, is at -1.30%, and for the 52-week low it comes to a value of 37.89%. The 20-day simple moving average is 1.48% and 11.38% for the 200-day simple moving average.

Volatility for the week is at 1.08%, and for the month it is 1.21%. Becton, Dickinson and Company, has a target price of 183.18.

In terms of debt, long term debt/equity is 1.31, and for total debt/equity Becton, Dickinson and Company has 1.48. The gross margin is 43.50%, while operating margin is 13.20%, the profit margin is 9.20%. The current ratio is 1.5 and the quick ratio is 1.1.

Insider ownership is at 0.20%, with instituitional ownership at 84.90%. Becton, Dickinson and Company has a payout ratio of 48.10%. With the total shares outstanding coming to 213.08. The shares float is 212.33, with the float short at 1.37%, with short ratio coming to 3.47.

In terms of returns, the return on assets see Becton, Dickinson and Company, get 4.30%, with its returns on investment at 5.20%. Return on equity is 15.10%. So will the investors see the target price of 183.18, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Peter Clarke

Leave a Comment